- ►centad.org [PDF] WH Shrank, T Hoang, SL Ettner, PA Glassman, … - Archives of Internal Medicine, 2006 - Am Med Assoc Methods We analyzed pharmacy claims filled between October 1, 2001, and October
1, 2003, from a large health plan for 6 classes of chronic medications:
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, calcium channel ... Cited by 76 - Related articles - All 6 versions
- ►annals.org W Yin, A Basu, JX Zhang, A Rabbani, DO … - Annals of Internal Medicine, 2008 - Am Coll Physicians Annals. Search Annals : Advanced search. ... Cited by 45 - Related articles - All 7 versions
WH Shrank, HN Young, SL Ettner, P Glassman … - Am J Manag Care, 2005 - ajmc.com Over the last 5 years, 3-tier pharmaceutical ben- efit systems have become the
dominant phar- macy benefit structure in the United States.1 As recently as
1998, only 8% of Americans with prescrip- tion drug coverage were enrolled ... Cited by 32 - Related articles - View as HTML - All 5 versions
- ►nih.gov WH Shrank, SA Fox, A Kirk, SL Ettner, CH … - Journal of general internal medicine, 2006 - Springer William H. Shrank, MD, MSHS, 1,2 Sarah A. Fox, EdD, 5,6 Adele Kirk, MS, 5 Susan
L. Ettner, PhD, 5 ... Clairessa H. Cantrell, BA, 5,6 Peter Glassman, MBBS, MSc,
3,4,5 Steven M. Asch, MD, MPH 3,4,5 Cited by 29 - Related articles - BL Direct - All 9 versions
WH Shrank, SM Asch, J Adams, C Setodji, EA … - Medical care, 2006 - journals.lww.com Background: Despite rising annual expenditures for prescription drugs, little
systematic information is available concerning the quality of pharmacologic care
for adults in the United States. We evaluated how frequently appropriate ... Cited by 27 - Related articles - BL Direct - All 7 versions
W Shrank, J Avorn, C Rolon, P Shekelle - Annals of Pharmacotherapy, 2007 - Harvey Whitney Books With the passage of the Medicare Modernization Act, the US federal government
has a dramatically expanded role in the provision of prescription drugs to
Americans.1,2 This investment has led to even greater attention to the ... Cited by 18 - Related articles - BL Direct - All 4 versions
EM DeWitt, HA Glick, DA Albert, MM Joffe, F … - Archives of Internal Medicine, 2006 - Am Med Assoc Background Rheumatoid arthritis is a chronic debilitating disease that affects
1% of the population. Tumor necrosis factor inhibitors, such as etanercept and
infliximab, have revolutionized the treatment of rheumatoid arthritis by ... Cited by 13 - Related articles - BL Direct - All 7 versions
WH Shrank, GI Joseph, NK Choudhry, HN … - AMERICAN JOURNAL OF MANAGED CARE, 2006 - hcplive.com Exposure to rapidly rising prescription drug costs has prompted insurers and
policy makers to cre- ate various cost-control strategies to improve awareness
of, and sensitivity to, these costs. In- terventions have been created to ... Cited by 12 - Related articles - View as HTML - BL Direct - All 5 versions
WH Shrank, SM Asch, GJ Joseph, HN Young, … - The Annals of pharmacotherapy, 2006 - Harvey Whitney Books Health plans have broadly instituted pharmacy benefit designs that use financial
incentives to influence pre- scribing. In 2004, approximately 70% of Americans
with employer-sponsored pharmacy benefit coverage were en- rolled in ... Cited by 7 - Related articles - BL Direct - All 5 versions
DE Havrda, BA Omundsen, W Bender, MA … - Annals of internal medicine, 2005 - Am Coll Physicians Background: Low-income Medicare beneficiaries without prescription benefits have
high out-of-pocket medication expenses that can discourage adherence to
treatment regimens. The Medicare Prescription Drug, Improvement, and ... Cited by 6 - Related articles - BL Direct - All 5 versions
